Wells Fargo & Company »

Blueprint Medicines shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Blueprint Medicines (BPMC) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Blueprint Medicines

Tip: Access up to 7 years of quarterly data

All positions including Blueprint Medicines held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Blueprint Medicines by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.3M 25k 92.24
2023-09-30 $2.7M 53k 50.22
2023-06-30 $3.5M 56k 63.20
2022-12-31 $2.0M 45k 43.81
2022-09-30 $632k 9.5k 66.14
2022-06-30 $513k 10k 50.74
2022-03-31 $2.7M 42k 63.88
2021-12-31 $7.0M 65k 107.69
2021-09-30 $8.6M 83k 102.81
2021-06-30 $7.2M 82k 88.79
2021-03-31 $9.0M 93k 97.23
2020-12-31 $6.9M 62k 112.09
2020-09-30 $4.1M 44k 92.63
2020-06-30 $4.3M 55k 78.07
2020-03-31 $3.2M 55k 58.38
2019-12-31 $2.9M 36k 80.11
2019-09-30 $3.1M 42k 73.55
2019-06-30 $3.9M 41k 94.25
2019-03-31 $2.7M 34k 80.05
2018-12-31 $1.8M 33k 53.92
2018-09-30 $2.6M 33k 78.05
2018-06-30 $1.3M 20k 63.49
2018-03-31 $3.3M 36k 91.70
2017-12-31 $1.8M 24k 75.40
2017-06-30 $1.5M 29k 50.69
2017-03-31 $877k 22k 39.98
2016-12-31 $439k 16k 28.08
2016-09-30 $203k 6.8k 29.67
2016-06-30 $139k 6.8k 20.32
2016-03-31 $71k 4.0k 17.98
2015-12-31 $84k 3.2k 26.49
2015-09-30 $68k 3.2k 21.35